Electrolyzed Hydrogen Water Alleviates Abdominal Pain through Suppression of Colonic Tissue Inflammation in a Rat Model of Inflammatory Bowel Disease.
Di Hu, Tianliang Huang, Mika Shigeta, Yuta Ochi, Shigeru Kabayama, Yasuyoshi Watanabe, Yilong Cui · Nutrients · 2022
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, meanwhile, the increased MPO level in the EHW-administered group significantly reduced 2 ( p = 0.0011) and 4 ( p = 0.0009) days post TNBS treatment (two-way ANOVA followed by Bonferroni’s multiple comparison procedure). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in rats. Meanwhile, the increased MPO level in the EHW-administered group significantly reduced 2 ( p = 0.0011) and 4 ( p = 0.0009) days post TNBS treatment (two-way ANOVA followed by Bonferroni’s multiple comparison procedure).
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 30 min. Meanwhile, the increased MPO level in the EHW-administered group significantly reduced 2 ( p = 0.0011) and 4 ( p = 0.0009) days post TNBS treatment (two-way ANOVA followed by Bonferroni’s multiple comparison procedure). The authors concluded that these results suggest that the EHW prevented the overproduction of ROS due to its powerful free-radical scavenging ability and blocked the crosstalk between oxidative stress and inflammation, thereby suppressing colonic inflammation and alleviating abdominal pain. For example, a study based on a gastric injury model showed that molecular hydrogen showed powerful free-radical scavenging properties to remove cytotoxic ROS and rapidly diffused across membranes to protect stomach tissue from aspirin-induced inflammatory injury [ 17 ].
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment. The reported treatment duration was 30 min.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.